药品注册申请号:005264
申请类型:NDA (新药申请)
申请人:HOSPIRA
申请人全名:HOSPIRA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
004 PANHEPRIN HEPARIN SODIUM INJECTABLE;INJECTION 1,000 UNITS/ML No No None 1943/05/04 Approved Prior to Jan 1, 1982 Discontinued
006 PANHEPRIN HEPARIN SODIUM INJECTABLE;INJECTION 5,000 UNITS/ML No No None Approved Prior to Jan 1, 1982 Discontinued
007 PANHEPRIN HEPARIN SODIUM INJECTABLE;INJECTION 10,000 UNITS/ML No No None Approved Prior to Jan 1, 1982 Discontinued
008 PANHEPRIN HEPARIN SODIUM INJECTABLE;INJECTION 20,000 UNITS/ML No No None Approved Prior to Jan 1, 1982 Discontinued
009 PANHEPRIN HEPARIN SODIUM INJECTABLE;INJECTION 40,000 UNITS/ML No No None Approved Prior to Jan 1, 1982 Discontinued
010 HEPARIN LOCK FLUSH HEPARIN SODIUM INJECTABLE;INJECTION 100 UNITS/ML No No None Approved Prior to Jan 1, 1982 Discontinued
013 HEPARIN SODIUM PRESERVATIVE FREE HEPARIN SODIUM INJECTABLE;INJECTION 2,000 UNITS/ML No No None 1986/04/07 Discontinued
014 HEPARIN SODIUM PRESERVATIVE FREE HEPARIN SODIUM INJECTABLE;INJECTION 2,500 UNITS/ML No No None 1986/04/07 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2011/12/23 SUPPL-93(补充) Approval Labeling STANDARD
2000/03/21 SUPPL-73(补充) Approval Labeling STANDARD
1998/09/16 SUPPL-70(补充) Approval Labeling STANDARD
1992/10/29 SUPPL-65(补充) Approval Labeling STANDARD
1992/03/24 SUPPL-63(补充) Approval Labeling
1991/07/24 SUPPL-60(补充) Approval Labeling
1988/11/22 SUPPL-58(补充) Approval Labeling
1985/05/21 SUPPL-50(补充) Approval Efficacy
1984/10/04 SUPPL-48(补充) Approval Labeling
1981/10/26 SUPPL-45(补充) Approval Labeling
1981/05/15 SUPPL-42(补充) Approval Efficacy
1981/04/22 SUPPL-43(补充) Approval Labeling
1981/02/18 SUPPL-40(补充) Approval Labeling
1980/09/29 SUPPL-37(补充) Approval Labeling
1980/07/02 SUPPL-39(补充) Approval Labeling
1978/05/15 SUPPL-31(补充) Approval Labeling
1978/01/04 SUPPL-29(补充) Approval Labeling
1977/11/04 SUPPL-27(补充) Approval Labeling
1976/09/22 SUPPL-20(补充) Approval Labeling
1976/09/22 SUPPL-19(补充) Approval Labeling
1976/09/22 SUPPL-18(补充) Approval Labeling
1943/05/04 ORIG-1(原始申请) Approval Type 5 - New Formulation or New Manufacturer STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
本品无治疗等效药品
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database